GlobalData on MSN11h
Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback
The pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...
Bucknell University12d
Bucknell Study Optimizes Deep Brain Stimulation for Parkinson’s Disease
Professor Karlo Malaga leads research focusing on pinpointing specific areas in the subthalamic region where deep brain ...
Aldergrove Star9d
VIDEO: Langley's Aldor Acres farm campaigns against Parkinson's
Evelyn Paulson from Port Coquitlam was smiling as the goats crowded around her and mom Morgan at Langley's Aldor Acres farm ...
redandblack.com12d
UGA researchers use bugs to battle Parkinson’s
From family members, to friends, to beloved members of society, Parkinson’s disease impacts more than 10 million people ...
TMCnet1d
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson's Disease at AD/PD 2025
This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...
Alzheimer's Society1mon
Parkinson's disease dementia
People with Parkinson's disease are more likely to develop certain types of dementia. Find out about the causes, symptoms and treatments. Parkinson’s disease is a brain disease that affects around 145 ...